Dr Stella Sung Ph.D. published findings on the application of ultraviolet (UVC) light in germicidal wavelengths for disinfection of contaminated air and surfaces. In this analysis, the Sterile-Bright™ product line emerged as having the most promising UV disinfecting technology.
Or read below for excerpts from the white paper
As confirmed by Dr. Nardell, UV disinfection has been a proven and validated technology for the disinfection of pathogens in air as well as on surfaces for several decades.
Unlike other UV lights, the Sterile-Bright™ UV light is in the right frequency range to disrupt the oxygen molecule, generating ozone (O3), which is a strong sterilizing agent. This combination of UV light and ozone provides an optimum solution for disinfection of contaminated air and surfaces.
Different UV-C sources with different performance characteristics have been utilized for disinfection. The most common UV-C light sources for disinfection include:
• low vapor pressure mercury UV lamps, which emit UV light at 254 nm
• UV light-emitting diode (UV-LEDs) lamps, which emit UV light at wavelengths between 255 and 280 nm
• far-UV-C radiating excimer and micro-plasma lamps, which emit UV light at 200−240 nm.
In contrast, the Sterile-Bright™ UV light emits UV light across most of the UV spectrum, from 180nm to 457nm.7 This is one of several key advantages in disinfection that the Sterile-Bright™ UV light product line boasts over these other UV sources. Sterile-Bright™
UV light emits in the UV-A, UV-B, UV-C, and VUV ranges. In the VUV range of 180nm - 200nm, ozone is produced, which has its own germicidal activity, as highlighted in a later section of the paper.
In addition, Sterile-Bright™ has significantly higher power output than conventional fluorescent UV bulbs, which typically range from only 10-watts to 40-watts and therefore require placement near the target to deliver effective UV doses. The efficacy of Sterile-Bright™ is further enhanced by its 360-degree radial UV distribution.
Dr. Sung earned her Ph.D. in physical chemistry at Harvard University under Professor Dudley Herschbach (1986 Nobel Laureate in Chemistry). Dr. Sung was a National Science Pre-Doctoral Fellow as well as a NATO Postdoctoral Fellow at Harvard University. The bulk of Dr. Sung’s career has been in C-level positions at life science companies. She is currently serving as Chief Business Officer of Aegea Biotechnologies, a private company developing next generation molecular diagnostic tests for SARS-CoV-2, and she is passionate about identifying and applying the best science to address the global health pandemic.